Article
The presence of resistance mutations to protease and polymerase inhibitors in Hepatitis C virus sequences from the Los Alamos databank.
Journal of viral hepatitis - 1 Jun 2013
Alves R, Queiroz A T L, Pessoa M G, da Silva E F, Mazo D F C, Carrilho F J, Carvalho-Filho R J, de Carvalho I M V G
Abstract excerpt
Several new direct-acting antiviral (DAA) drugs are in development for chronic hepatitis C viral (HCV) infection, and NS3-NS4A serine protease and the NS5B RNA-dependent RNA polymerase have been the major targets. HCV variants displaying drug-resistant phenotypes have been observed both in vitro and during clinical trials. Our aim was to characterize amino acid changes at positions previously associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
